WHO calls for greater global cooperation in the development and supply of new crown vaccines

GENEVA, Aug. 13 (Xinhua Liu Qu) The World Health Organization (WHO) said on the 13th that competition should be avoided in the development and supply of new crown vaccines, and the world should strengthen solidarity and cooperation so that countries can share risks, share benefits and have a better hope of finding safe and effective new crown vaccines.
WHO Director-General Tan Desser announced at a press conference on the same day, as of the 13th, the WHO-led "Access to the New Coronary Pneumonia Tool Accelerator" international cooperation initiative has nine candidate vaccines are in Phase 2 or Phase 3 clinical trials, the number is still growing. A number of countries have signed up or expressed interest in participating in the new crown vaccine access programme under the initiative.
said developing a new crown vaccine was a long, complex, risky and expensive process. The world needs many different types of vaccine candidates to maximize the chances of finding a successful solution. When a successful new vaccine is found, there are problems such as high demand and competition for supply that can drive up prices, which "can only be addressed through global solidarity, (enhanced) public sector investment, and (expanded) participation".
Aylward, a senior adviser to the WHO Director-General, says a growing number of countries have come to realize that vaccination of their nationals alone will not eliminate the epidemic because of the close links between the global economy, trade and trade. He suggested that the global development and procurement of new crown vaccines should be coordinated.
WHO Assistant Director-General Marian hera Simo said in response to a question from Xinhua that WHO has been actively discussing with member countries the equitable distribution of the new crown vaccine as a public health product, with the aim of ensuring that the vaccine benefits all countries and populations.
Simon believes that although WHO currently has more than 200 new crown candidate vaccines on the register, it has not yet completed all clinical trials, so it is not yet known which is really effective and cannot "bet" on one or more candidate vaccines. She called on all countries to join the global initiative "Access to a Tool Accelerator to Fight New Coronary Pneumonia" to increase access to safe and effective vaccines by sharing collaboration.